Emerging drug therapies for preventing spontaneous preterm labor and preterm birth.
about
The Human Ureaplasma Species as Causative Agents of ChorioamnionitisThe choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban.Periodontal disease and bacterial vaginosis as genetic and environmental markers for the risk of spontaneous preterm labor and preterm birth.
P2860
Emerging drug therapies for preventing spontaneous preterm labor and preterm birth.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Emerging drug therapies for preventing spontaneous preterm labor and preterm birth.
@ast
Emerging drug therapies for preventing spontaneous preterm labor and preterm birth.
@en
type
label
Emerging drug therapies for preventing spontaneous preterm labor and preterm birth.
@ast
Emerging drug therapies for preventing spontaneous preterm labor and preterm birth.
@en
prefLabel
Emerging drug therapies for preventing spontaneous preterm labor and preterm birth.
@ast
Emerging drug therapies for preventing spontaneous preterm labor and preterm birth.
@en
P2860
P1476
Emerging drug therapies for preventing spontaneous preterm labor and preterm birth.
@en
P2093
Anilla N Jaggat
Ronald F Lamont
P2860
P304
P356
10.1517/13543784.16.3.337
P407
P577
2007-03-01T00:00:00Z